{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:58:57Z","timestamp":1787237937519,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.neurol.2022.10.006","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T08:07:59Z","timestamp":1676102879000},"page":"533-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Non-infectious meningitis and CNS demyelinating diseases: A conceptual review"],"prefix":"10.1016","volume":"179","author":[{"given":"M.","family":"Etemadifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fereidan-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Kargaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Abhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aghababaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jannesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ganjalikhani-Hakemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1808-0443","authenticated-orcid":false,"given":"H.","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2022.10.006_bib0380","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jcv.2017.07.016","article-title":"Aseptic meningitis in adults and children: Diagnostic and management challenges","volume":"94","author":"Shukla","year":"2017","journal-title":"J Clin Virol."},{"key":"10.1016\/j.neurol.2022.10.006_bib0385","doi-asserted-by":"crossref","unstructured":"Tattevin P, Tchamgou\u00e9 S, Belem A, B\u00e9n\u00e9zit F, Pronier C, Revest M. Aseptic meningitis. Rev Neurol (Paris). 175(7-8):475-80.","DOI":"10.1016\/j.neurol.2019.07.005"},{"issue":"4","key":"10.1016\/j.neurol.2022.10.006_bib0390","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis spectrum disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin Proc."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0395","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J Neuroinflammation."},{"issue":"2","key":"10.1016\/j.neurol.2022.10.006_bib0400","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"issue":"18","key":"10.1016\/j.neurol.2022.10.006_bib0405","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1212\/WNL.0000000000003278","article-title":"Clinical reasoning: bacterial meningitis causing a neuromyelitis optica flare","volume":"87","author":"Saab","year":"2016","journal-title":"Neurology."},{"issue":"1\u20132","key":"10.1016\/j.neurol.2022.10.006_bib0410","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J Neurol Sci."},{"issue":"4","key":"10.1016\/j.neurol.2022.10.006_bib0415","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00415-020-10300-z","article-title":"Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder","volume":"268","author":"Netravathi","year":"2021","journal-title":"J Neurol."},{"key":"10.1016\/j.neurol.2022.10.006_bib0420","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3389\/fimmu.2018.02753","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disorders: toward a new spectrum of inflammatory demyelinating CNS disorders?","volume":"9","author":"Di Pauli","year":"2018","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.neurol.2022.10.006_bib0425","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0430","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.neurol.2022.10.006_bib0435","doi-asserted-by":"crossref","first-page":"102013","DOI":"10.1016\/j.msard.2020.102013","article-title":"Aseptic meningitis as an atypical manifestation of neuromyelitis optica spectrum disorder flare","volume":"41","author":"Shi","year":"2020","journal-title":"Mult Scler Relat Disord."},{"issue":"1.","key":"10.1016\/j.neurol.2022.10.006_bib0440","article-title":"Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders","volume":"8","author":"Rinaldi","year":"2021","journal-title":"Neurol Neuroimmunol neuroinflammation."},{"key":"10.1016\/j.neurol.2022.10.006_bib0445","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.msard.2018.10.003","article-title":"Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations","volume":"27","author":"Narayan","year":"2019","journal-title":"Mult Scler Relat Disord."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0450","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12883-020-02041-3","article-title":"Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis","volume":"21","author":"Shen","year":"2021","journal-title":"BMC Neurol."},{"issue":"22","key":"10.1016\/j.neurol.2022.10.006_bib0455","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.2169\/internalmedicine.2845-19","article-title":"Aseptic meningitis as an initial manifestation of anti-myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"58","author":"Suzuki","year":"2019","journal-title":"Intern Med."},{"key":"10.1016\/j.neurol.2022.10.006_bib0460","doi-asserted-by":"crossref","first-page":"102455","DOI":"10.1016\/j.msard.2020.102455","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis with considerable white blood cell elevation in cerebrospinal fluid","volume":"46","author":"Miller","year":"2020","journal-title":"Mult Scler Relat Disord."},{"issue":"15 Supplement 1.","key":"10.1016\/j.neurol.2022.10.006_bib0465","article-title":"Clinical episode of aseptic meningitis with leptomeningeal enhancement in patient with anti-MOG antibodies","volume":"90","author":"Sarangi","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.neurol.2022.10.006_bib0470","doi-asserted-by":"crossref","first-page":"102050","DOI":"10.1016\/j.msard.2020.102050","article-title":"MOG antibody associated demyelinating syndrome presenting as aseptic meningitis in a 6-year-old boy","volume":"41","author":"Leinert","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.neurol.2022.10.006_bib0475","doi-asserted-by":"crossref","first-page":"476960","DOI":"10.1016\/j.jneuroim.2019.05.001","article-title":"MOG antibody seropositive aseptic meningitis: a new clinical phenotype","volume":"333","author":"Nagabushana","year":"2019","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.neurol.2022.10.006_bib0480","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.msard.2018.07.028","article-title":"A case of anti-MOG antibody-positive unilaterally dominant meningoencephalitis followed by longitudinally extensive transverse myelitis","volume":"25","author":"Sugimoto","year":"2018","journal-title":"Mult Scler Relat Disord."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0485","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12883-019-1324-4","article-title":"Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome","volume":"19","author":"Zhong","year":"2019","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0490","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs. aquaporin 4 IgG disease","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurol.2022.10.006_bib0495","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jns.2018.01.042","article-title":"Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures","volume":"387","author":"Gutman","year":"2018","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.neurol.2022.10.006_bib0500","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fneur.2019.00415","article-title":"Seizure and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis in a retrospective cohort of Chinese patients","volume":"10","author":"Zhong","year":"2019","journal-title":"Front Neurol."},{"issue":"2","key":"10.1016\/j.neurol.2022.10.006_bib0505","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol neuroinflammation."},{"issue":"8","key":"10.1016\/j.neurol.2022.10.006_bib0510","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.0000000000001292","article-title":"Can leptomeningeal enhancement be linked to multiple sclerosis?","volume":"84","author":"Barkhof","year":"2015","journal-title":"Neurology."},{"issue":"12","key":"10.1016\/j.neurol.2022.10.006_bib0515","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jamaneurol.2015.2869","article-title":"Targeting central nervous system B cells in progression of multiple sclerosis: is intrathecal anti-CD20 a therapeutic option?","volume":"72","author":"Fereidan-Esfahani","year":"2015","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.neurol.2022.10.006_bib0520","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/NEN.0b013e3181b4bf8f","article-title":"Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis","volume":"68","author":"Kooi","year":"2009","journal-title":"J Neuropathol Exp Neurol."},{"issue":"4","key":"10.1016\/j.neurol.2022.10.006_bib0525","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1750-3639.2009.00343.x","article-title":"Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients","volume":"20","author":"Torkildsen","year":"2010","journal-title":"Brain Pathol."},{"issue":"12","key":"10.1016\/j.neurol.2022.10.006_bib0530","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1177\/1352458518819098","article-title":"Severe meningo-\/encephalitis after daclizumab therapy for multiple sclerosis","volume":"25","author":"Stork","year":"2019","journal-title":"Mult Scler."},{"issue":"5","key":"10.1016\/j.neurol.2022.10.006_bib0535","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1212\/NXI.0000000000000479","article-title":"Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS","volume":"5","author":"Scheibe","year":"2018","journal-title":"Neurol Neuroimmunol neuroinflammation."},{"issue":"5","key":"10.1016\/j.neurol.2022.10.006_bib0540","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.0b013e31827f0f42","article-title":"CNS vasculitis in a patient with MS on daclizumab monotherapy","volume":"80","author":"Ohayon","year":"2013","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.neurol.2022.10.006_bib0545","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.molmed.2018.04.003","article-title":"Advances in meningeal immunity","volume":"24","author":"Rua","year":"2018","journal-title":"Trends Mol Med."},{"issue":"5","key":"10.1016\/j.neurol.2022.10.006_bib0550","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/eji.201243040","article-title":"Efficiently stimulated adult microglia cross-prime naive CD8+ T cells injected in the brain","volume":"43","author":"Jarry","year":"2013","journal-title":"Eur J Immunol."},{"issue":"23","key":"10.1016\/j.neurol.2022.10.006_bib0555","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1016\/j.febslet.2011.04.066","article-title":"How do immune cells overcome the blood-brain barrier in multiple sclerosis?","volume":"585","author":"Larochelle","year":"2011","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.neurol.2022.10.006_bib0560","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurol.2022.10.006_bib0565","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature","volume":"9","author":"Shan","year":"2018","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.neurol.2022.10.006_bib0570","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol."},{"issue":"2","key":"10.1016\/j.neurol.2022.10.006_bib0575","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jnnp-2017-316583","article-title":"Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients","volume":"89","author":"Iorio","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.neurol.2022.10.006_bib0580","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","article-title":"Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year","volume":"321","author":"Dubey","year":"2018","journal-title":"J Neuroimmunol."},{"issue":"2","key":"10.1016\/j.neurol.2022.10.006_bib0585","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.24200","article-title":"Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms","volume":"76","author":"Irani","year":"2014","journal-title":"Ann Neurol."},{"issue":"3","key":"10.1016\/j.neurol.2022.10.006_bib0590","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ene.13531","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study","volume":"25","author":"Long","year":"2018","journal-title":"Eur J Neurol."},{"issue":"3","key":"10.1016\/j.neurol.2022.10.006_bib0595","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/WCO.0000000000000676","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy","volume":"32","author":"Kunchok","year":"2019","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.neurol.2022.10.006_bib0600","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fneur.2018.00251","article-title":"Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies","volume":"9","author":"Yang","year":"2018","journal-title":"Front Neurol."},{"issue":"6","key":"10.1016\/j.neurol.2022.10.006_bib0605","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/MAJ.0b013e3182760e3b","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis","volume":"345","author":"Lim","year":"2013","journal-title":"Am J Med Sci."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0610","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1941874413496792","article-title":"The diagnostic conundrum and treatment dilemma of a patient with a rapidly progressive encephalopathy","volume":"4","author":"Beatty","year":"2014","journal-title":"Neurohospitalist."},{"issue":"3","key":"10.1016\/j.neurol.2022.10.006_bib0615","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jpag.2017.12.009","article-title":"Ovarian teratoma associated with coexisting anti-n-methyl-d-aspartate receptor and glial fibrillary acidic protein autoimmune meningoencephalitis in an adolescent girl: a case report","volume":"31","author":"Martin","year":"2018","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"8","key":"10.1016\/j.neurol.2022.10.006_bib0620","first-page":"e5415","article-title":"Anti-N-methyl-D-aspartate encephalitis concomitantly with tall-cell variant papillary thyroid carcinoma","volume":"11","author":"Mahadeen","year":"2019","journal-title":"Cureus."},{"issue":"3","key":"10.1016\/j.neurol.2022.10.006_bib0625","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jemermed.2020.07.006","article-title":"A pounding problem: a case of recurrent headache caused by anti-NMDA receptor encephalitis","volume":"60","author":"Norton","year":"2021","journal-title":"J Emerg Med."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0630","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12879-020-4761-1","article-title":"Case report: meningitis as a presenting feature of anti-NMDA receptor encephalitis","volume":"20","author":"Stavrou","year":"2020","journal-title":"BMC Infect Dis."},{"issue":"11","key":"10.1016\/j.neurol.2022.10.006_bib0635","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.neurol.2022.10.006_bib0640","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0645","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.neurol.2022.10.006_bib0650","doi-asserted-by":"crossref","first-page":"e01012","DOI":"10.1002\/brb3.1012","article-title":"Prodromal headache in anti-NMDAR encephalitis: an epiphenomenon of NMDAR autoimmunity","volume":"8","author":"Tominaga","year":"2018","journal-title":"Brain Behav."},{"issue":"2","key":"10.1016\/j.neurol.2022.10.006_bib0655","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"issue":"22","key":"10.1016\/j.neurol.2022.10.006_bib0660","doi-asserted-by":"crossref","first-page":"e2302","DOI":"10.1212\/WNL.0000000000009239","article-title":"Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies","volume":"94","author":"Martinez-Hernandez","year":"2020","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.neurol.2022.10.006_bib0665","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/1570159X11311030002","article-title":"NMDA receptors in glial cells: pending questions","volume":"11","author":"Dzamba","year":"2013","journal-title":"Curr Neuropharmacol."},{"key":"10.1016\/j.neurol.2022.10.006_bib0670","doi-asserted-by":"crossref","first-page":"595417","DOI":"10.3389\/fimmu.2020.595417","article-title":"Case report: overlapping multiple sclerosis with anti-N-methyl-D-aspartate receptor encephalitis: a case report and review of literature","volume":"11","author":"Huang","year":"2020","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.neurol.2022.10.006_bib0675","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.24117","article-title":"Overlapping demyelinating syndromes and anti\u2013N-methyl-D-aspartate receptor encephalitis","volume":"75","author":"Titulaer","year":"2014","journal-title":"Ann Neurol."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0680","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10072-020-04518-y","article-title":"\u201cNMDA receptor spectrum disorder\u201d in the differential diagnosis of demyelinating disorders of the CNS: optic neuritis and myelitis","volume":"42","author":"Etemadifar","year":"2021","journal-title":"Neurol Sci."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0685","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-065X.2011.01011.x","article-title":"Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28\/B7 family","volume":"241","author":"Bour-Jordan","year":"2011","journal-title":"Immunol Rev."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0690","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/clim.1998.4684","article-title":"Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice","volume":"91","author":"Perrin","year":"1999","journal-title":"Clin Immunol."},{"issue":"15","key":"10.1016\/j.neurol.2022.10.006_bib0695","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1.","key":"10.1016\/j.neurol.2022.10.006_bib0700","article-title":"Daclizumab: mechanisms of action, therapeutic efficacy, adverse events and its uncovering the potential role of innate immune system recruitment as a treatment strategy for relapsing multiple sclerosis","volume":"7","author":"Cohan","year":"2019","journal-title":"Biomedicines."},{"key":"10.1016\/j.neurol.2022.10.006_bib0705","doi-asserted-by":"crossref","first-page":"592017","DOI":"10.3389\/fcimb.2020.592017","article-title":"The use of adjunctive steroids in central nervous infections","volume":"10","author":"Gundamraj","year":"2020","journal-title":"Front Cell Infect Microbiol."},{"issue":"2","key":"10.1016\/j.neurol.2022.10.006_bib0710","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann Neurol."},{"issue":"4","key":"10.1016\/j.neurol.2022.10.006_bib0715","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0720","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat Rev Dis Prim."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0725","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000505730","article-title":"Overlapping clinical syndromes in patients with glial fibrillary acidic protein IgG","volume":"27","author":"Lin","year":"2020","journal-title":"Neuroimmunomodulation."},{"key":"10.1016\/j.neurol.2022.10.006_bib0730","series-title":"Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder","author":"Wang","year":"2012"},{"key":"10.1016\/j.neurol.2022.10.006_bib0735","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.msard.2019.01.050","article-title":"Suspected bacterial meningoencephalomyelitis as the trigger or presentation of neuromyelitis optica spectrum disorder flare","volume":"30","author":"He","year":"2019","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.neurol.2022.10.006_bib0740","doi-asserted-by":"crossref","first-page":"105813","DOI":"10.1016\/j.clineuro.2020.105813","article-title":"Fever, nausea and vomiting, and CSF pleocytosis must be meningoencephalitis, right? No, think again!","volume":"194","author":"Rocha","year":"2020","journal-title":"Clin Neurol Neurosurg."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0745","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10072-008-0002-x","article-title":"Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis","volume":"30","author":"Lepur","year":"2009","journal-title":"Neurol Sci."},{"issue":"1","key":"10.1016\/j.neurol.2022.10.006_bib0750","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12883-021-02133-8","article-title":"Meningitis as a recurrent manifestation of anti-AQP4\/anti-MOG negative neuromyelitis optica spectrum disorder: a case report","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Neurol."}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723007567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723007567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:46:50Z","timestamp":1758520010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723007567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0035378723007567"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2022.10.006","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-infectious meningitis and CNS demyelinating diseases: A conceptual review","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2022.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}